Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Comparing Treatment of Knee Osteoarthritis With Triamcinolone Injections Using 40mg With Landmark Guidance and 20mg With Ultrasound Guidance [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing knee osteoarthritis treatment with Triamcinolone injections: 40 mg given with landmark guidance versus 20 mg given with ultra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Sosi Dzhugarian | Conditions: Knee Arthritis Osteoarthritis | Phase 4 | Status: ENROLLING_BY_INVITATION